LONDON, UK AND PLANO, TX Belluscura PLC, in conjunction with its exclusive research partner Separation Design Group, announced today the recent filing of a patent application covering novel integrated portable extracorporeal oxygenation and carbon dioxide removal systems. The latest patent application covers systems for treating people suffering from acute respiratory distress syndrome (ARDS). Typical causes of […]
Visit Belluscura at Booth 65 at the UK Investor Show! See a live demonstration of the X-PLO2R portable oxygen concentrator, learn more about its unique technology and multiple advantages, and meet Belluscura’s CEO Bob Rauker and CFO Tony Dyer. Investment Notice: Neither Belluscura or Crowdcube is soliciting investors in the United States, Canada or Japan or […]
To date, we have brought on more than 100 investors from 12 countries and we are very thankful for all the interest in, and support of the X-PLOR. Our goal is to help patients suffering from chronic lung diseases, such as COPD, to enjoy more active and fulfilling lifestyles. Please join us in helping millions […]
Belluscura will be demonstrating the X-PLOR at the UK Investor Show on March 30. Come see us at Booth 65 for a hands-on experience with the world’s first modular portable oxygen concentrator.
We are getting numerous inquiries about the X-PLO2R being presented at the UK Investor Show. Having received so much interest, we decided to extend our crowdfunding campaign until April 5. Come see us at the show March 30 and don’t miss out on this unique investment opportunity! Investment Notice: Neither Belluscura or Crowdcube is soliciting investors […]
Belluscura will be presenting on March 30 at the UK Investor Show. Come experience in-person the X-PLO2R’s unique features and advantages, and meet Belluscura CEO Bob Rauker and CFO Tony Dyer.
After just two weeks of our @Crowdcube campaign, we are already at 48% of our funding target! We are excited to have brought on 73 investors from 9 countries. 16 days remaining in the campaign, so don’t miss out on this unique healthcare investment opportunity! Investment Notice: Neither Belluscura or Crowdcube is soliciting investors in […]